PATENT CLAIM ANALYSIS

Application Number: 16064692
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "265100"]

Abstract:
Disclosed is an antitumor effect potentiator for one or more other compounds having an antitumor effect, the antitumor effect potentiator comprising a novel pyrrolopyrimidine compound.

Claim (Index 2):
The antitumor effect potentiator according to  claim 1 , wherein in Formula (A),\n R1 is hydrogen, fluorine, or a hydroxy group; R2 is hydrogen, fluorine, or a hydroxy group; and R3 is an ethynylene group, or a monocyclic or bicyclic heteroarylene group having 1 to 4 of at least one kind of heteroatom selected from the group consisting of N, S, and O.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15122863', '15890470', '15708917', '15756366', '12310597']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7960113540389516
- 35 USC 102 Novelty (BERT): 0.5814998662848883
- Combined Prediction Score: 0.7745602052635453
- Mean Citation Score: 357.162248
- Max Citation Score: 477.41696
- Similarity Product: 412.2687240295409

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test